Innovation Pharmaceuticals Inc (IPIX)

[biodoc]

Thank you Karin. Also, there is a wealth of data and discussion of multiple mechanisms of action in the pre-clinical poster from 2011/12. Discussion of kevetrin's multiple mechanisms of action and the therapeutic implications of these multiple mechanisms are, imo, well worth revisiting.

2015 ASCO poster is a huge, huge validation. Now I find it much easier (and more believable) to further project the clinical work from the pre-clinical data.